Red bean extract reduces inflammation and increases survival in a murine sepsis model

Food Science and Biotechnology

Volumn 20, Issue 4, 2011, Pages 1125-1131

  Park, Siwoo ^a   Choi, Ki Choon ^b   Fang, Minghao ^a   Lim, Yung Chul ^b   Jeon, Young Mi ^a   Lee, Jeong Chae ^a,c  

^a Chonbuk National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

IgE; lipopolysaccharide; ovalbumin; red bean; sepsis

Indexed keywords

IGE; LIPOPOLYSACCHARIDES; OVALBUMIN; RED BEAN; SEPSIS;

DISEASES; ETHANOL; NITRIC OXIDE; PHENOLS;

MAMMALS;

MURINAE; MUS;

EID: 80053978876     PISSN: 12267708     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10068-011-0153-z     Document Type: Article

References (30)

1. Sung CS, Wong CS. Cellular mechanisms of neuroinflammatory pain: The role of interleukin-1β. Acta Anaesthesiol. Taiwan 45: 103-109 (2007).
2. Vuolteenaho K, Moilanen T, Knowles RG, Moilanen E. The role of nitric oxide in osteoarthritis. Scand. J. Rheumatol. 36: 247-258 (2007).
3. Murakami A. Chemoprevention with phytochemicals targeting inducible nitric oxide synthase. Forum Nutr. 61: 193-203 (2009).
4. Sung MJ, Davaatseren M, Kim W, Park SK, Kim SH, Hur HJ, Kim MS, Kim YS, Kwon DY. Vitisin A suppresses LPS-induced NO production by inhibiting ERK, p38, and NF-κB activation in RAW 264. 7 cells. Int. Immunopharmacol. 9: 319-323 (2009).
5. Hesslinger C, Strub A, Boer R, Ulrich WR, Lehner MD, Braun C. Inhibition of inducible nitric oxide synthase in respiratory diseases. Biochem. Soc. T. 37: 886-891 (2009).
6. Kang EH, Gebru E, Kim MH, Cheng H, Park SC. EstA protein, a novel virulence factor of Streptococcus pneumoniae, induces nitric oxide and pro-inflammatory cytokine production in RAW 264. 7 macrophages through NF-κB/MAPK. Microb. Pathogenesis 47: 196-201 (2009).
7. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res. 2007: 95103-95116 (2007).
8. Kanwar JR, Kanwar RK, Burrow H, Baratchi S. Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr. Med. Chem. 16: 2373-2394 (2009).
9. de la Lastra CA, Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications. Mol. Nutr. Food Res. 49: 405-430 (2005).
10. Vafeiadou K, Vauzour D, Spencer JP. Neuroinflammation and its modulation by flavonoids. Endocr. Metab. Immune Disord. -Drug Targets 7: 211-224 (2007).
11. Zhao QW, Huang X, Lou YJ, Weber N, Proksch P. Effects of ethanol extracts from adzuki bean (Phaseolus angularis Wight.) and lima bean (Phaseolus lunatus L.) on estrogen and progesterone receptor phenotypes of MCF-7/BOS cells. Phytother. Res. 21: 648-652 (2007).
12. Fang M, Lee SY, Park SM, Choi KC, Lee YJ, Cho HK, Cho SW, Whang WK, Lee JC. Anti-inflammatory potential of Phaseolus calcaratus Roxburgh, an oriental medicine, on LPS-stimulated RAW 264. 7 macrophages. J. Pharm. Pharmacol. 63: 120-128 (2011).
13. 2-mediated oxidative stress. Food Sci. Biotechnol. 20: 151-158 (2011).
14. Delayre-Orthez C, de Blay F, Frossard N, Pons F. Dose-dependent effects of endotoxins on allergen sensitization and challenge in the mouse. Clin. Exp. Allergy 34: 1789-1795 (2004).
15. Li XA, Everson W, Smart EJ. Nitric oxide, caveolae, and vascular pathology. Cardiovasc. Toxicol. 6: 1-13 (2006).
16. Cerra MC, Pellegrino D. Cardiovascular cGMP-generating systems in physiological and pathological conditions. Curr. Med. Chem. 14: 585-599 (2007).
17. Ponnuchamy B, Khalil RA. Cellular mediators of renal vascular dysfunction in hypertension. Am. J. Physiol.-Reg. I. 296: R1001-R1018 (2009).
18. Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN, Bertics PJ. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: The MEK/ERK pathway is not essential for nitric oxide and interleukin 1β production. J. Biol. Chem. 277: 9077-9087 (2002).
19. Kim JY, Shin JS, Ryu JH, Kim SY, Cho YW, Choi JH, Lee KT. Anti-inflammatory effect of anemarsaponin B isolated from the rhizomes of Anemarrhena asphodeloides in LPS-induced RAW 264. 7 macrophages is mediated by negative regulation of the nuclear factor-κB and p38 pathways. Food Chem. Toxicol. 47: 1610-1617 (2009).
20. Kim YW. Anti-inflammatory effects of liquiritigenin as a consequence of the inhibition of NF-kB-dependent iNOS and proinflammatory cytokines production. Brit. J. Pharmacol. 154: 165-173 (2008).
21. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci. 97: 439-447 (2006).
22. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. New Engl. J. Med. 348: 1546-1554 (2003).
23. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. Crit. Care Med. 25: 1095-1100 (1997).
24. Moore CC, Martin EN, Lee GH, Obrig T, Linden J, Scheld WM. An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. BMC Infect. Dis. 8: 141 (2008).
25. Bone RC, Grodzin CJ, Balk RA. Sepsis: A new hypothesis for pathogenesis of the disease process. Chest 112: 235-243 (1997).
26. Jain V, Singh PP, Silawat N, Patel R, Saxena A, Bharti PK, Shukla M, Biswas S, Singh N. A preliminary study on pro- and antiinflammatory cytokine profiles in Plasmodium vivax malaria patients from central zone of India. Acta Trop. 113: 263-268 (2010).
27. Nakane A, Okamoto M, Asano M, Kohanawa M, Minagawa T. Endogenous γ interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect. Immun. 63: 1165-1172 (1995).
28. Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intens. Care Med. 21(Suppl 2): S258-S263 (1995).
29. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit. Care Med. 30(1 Suppl): S58-S63 (2002).
30. Gérard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547-550 (1993).